Dr. Hemant P Thacker

MD (Bom), MRSH (Lond.), FACE (USA), FACP

91 9820073882 / 9821539993 / 022 23634859 / 23613882

Practising Since : 1979

Specialisation

Consulting Physician
Cardio-Metabolic Specialist

Dr. Hemant P Thacker is an eminent Physician practising in Mumbai. In addition to general Medicine and Therapeutics he specialises in Cardio-Metabolic disorders, and has more than three decades of experience in this field. He is currently available for consultation at Bhatia Hospital (Tardeo), Breach Candy Hospital (Breach Candy) and at his private clinic at Sukh Sagar near Chowpatty Beach in Mumbai.

After obtaining the MBBS degree from Seth GS Medical in 1978, Dr. Thacker did his MD... [+]

Testimonials

Fellowships

Fellow of the American College of Clinical Endocrinology (FACE).
USA

Accreditation

Chief Medical Advisor, Bennett, Coleman & Co. Ltd (The Times of India). 1990 onwards.
Chief Medical Advisor, Northern Marine Shipping Division (Navigation Medicine). 1994 onwards.
Medical Consultant, Mondial Assistance - a Paris-based International Insurance and Health Organization. 1998 onwards.

[+]

Recognition

Principal's Prize for the Best Student of the Year. Jai Hind College, Mumbai.
1974
Awarded the Vasant Phansalkar Scholarship and Gold Medal in Pharmacology for standing First in Pharmacology at the Second Year MBBS examination conducted by the Bombay University.
1975
Prize for the Best Intern of Seth GS Medical College and KEM Hospital.
1979

Research

Significance of Reciprocal Changes in the Anterior Chest Leads during Acute Inferior Wall Infarction – 53 Cases. Bombay University Project 1982.

Principal Investigator: Clinical Study of Verapamil 240mg SR (Sustained Release) in the Control of Mild to Moderate Hypertension – 20 Cases followed-up over 6 months. 1992.

[+]

Principal Investigator: Dygaid – A Clinical Experience of a New Antacid, Antiflatulent in Cases of Mild Clinical Dyspepsia – a 6-Month Study in 50 Cases.

Paper Published in the Bombay Hospital Journal Vol.35 No.3. (1995).

Principal Investigator: Clinical Efficacy of Ascending Concentrations of Nicotine Patches in the Treatment of Cigarette Smoking Withdrawal - Trial Conducted on 10 Patients on an OPD Basis. 1995-1996.

Principal Investigator: Evaluation of the Antibacterial Activity of Levofloxacin in patients hospitalised for Primary Respiratory Conditions. Conducted at Jaslok Hospital on 10 Patients – Trial Conducted for Aventis Pharma. 1998-1999.

Principal Investigator: The Use of Pen-filled Insulin in Ambulatory Patients of Type 2 Diabetes. A Clinical Study using Eli Lilly’s Short and Long Acting Human Insulins in 10 Patients on an OPD Basis. 2000-2001.

Principal Investigator: The Pioneering Study of the Efficacy of Chirally Pure Amlodipine in Essential Hypertension - A Double Blind Study using Chiral and Racemic Amlodipine in 20 Patients on an Outpatient Basis. 2001-2002.

Principal Investigator: The Efficacy of Metoprolol in an Extended Release Form – Seloken XL, in Essential Hypertension. A Nationwide OPD Study of 2000 Patients conducted by ASTRA over a period of 6 months. 2002.

Principal Investigator: The Use of Chirally Pure Atenolol in the Treatment of Mild to Moderate Hypertension in 50 Patients. A Double Blind Study spanning 7 Months conducted on an OPD Basis. Supervised and Sponsored by Emcure Pharma. 2002-2003.

Principal Investigator: The Use of Purified Fenugreek in lowering Sugar Levels and increasing Insulin Secretion on 10 Healthy Volunteers following repeated Glucose Challenges. Study conducted in conjunction with Innovasynth Technologies (USA) Ltd., Indian Branch. 2004.

Principal Investigator: A Global Study (Gemini ALAA-200 International Sites) to determine the Efficacy of Amlodipine and Atorvastatin in Combination (Caduet) in Patients of Essential Hypertension and Dyslipidemia - 15 Patients. 2004.

Principal Investigator: Double Blind Study to determine the Clinical Efficacy of Chirally Pure Pantoprazole in Comparison with Racemic Pantoprazole - an OPD Study of 50 Randomised Patients. 2004-2005.

Principal Investigator: A Comparative Study of Glycemic Control in 70 Diabetic Patients using Disposable Pen-filled Mixtard Insulin Vs Highly Purified as Part Insulin in Pen-filled Form. 2005.

Principal Investigator: A Study on 50 Patients with Idiopathic Fatty Liver (Non-Viral) using a Double Blind Method to Study the Efficacy of a Coded Drug. Bhatia Hospital. Sponsor – Charak Pharmaceuticals. 2005-2007.

Principal Investigator: A Double Blind Study comparing the Efficacy of a New Coded Statin with Atorva - 25 Patients. Conducted at Bhatia Hospital. 2005-2008.

Principal Investigator: A Double Blind, Placebo-controlled Study comparing the Efficacy New DPP4 Agent in Type 2 Diabetes. 2006-2008.

Principal Investigator: A Once-daily Dose-ranging Study of Study Drug (DPP4) versus Placebo in the Treatment of Type 2 Diabetes Mellitus in Drug Naïve Subjects. Phase II B. 2006-2008.

Principal Investigator: A Double Blind, Double Dummy, Parallel-Group International Study comparing Oral Rivaroxaban with Warfarin for the Prevention of Stroke in Patients with Non-Valvular Atrial Fibrillation. 2006-2010.

Principal Investigator: A Multinational, Multi-centre, Randomised, Double-Blind Study comparing the Efficacy and Safety of Study Drug with Enoxaparin for the Primary Prevention of Venous Thromboembolism in Acutely Ill Medical Patients with Restricted Mobility. 2007-2009.

Principal Investigator: A Placebo-Controlled, Randomised, Safety and Efficacy Study of BOTOX® (Botulinumtoxin Type A) Purified Neurotoxin Complex in Patients with Neurogenic Detrusor Overactivity and Neurological Respiratory Impairment. 2007-2010.

Principal Investigator: Randomised Dabigatran Etexilate Dose Finding Study in Patients with Acute Coronary Syndromes Post Index Event with Additional Risk Factors for Cardiovascular Complications also receiving Aspirin and Clopidogrel: Multi-centre, Prospective, Placebo-controlled Group Dose Escalation Trial. Phase II. 2008-2010.

Principal Investigator: A Registry to Study the Switch from Existing Insulin Treatment to another Insulin Treatment in Inadequately Controlled Type 1 and Type 2 Diabetes Patients. 2010-2011.

Principal Investigator: Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects with Comorbidities. A Randomised, Double-Blind, Placebo-controlled, Parallel Group, Multi-centre, Multinational Trial with Stratification of Subject to either 56 or 160 Weeks of Treatment based on Pre-diabetes Status at Randomization. 2010 - Ongoing.

Principal Investigator: A Double-Blind, Randomised, Placebo-controlled, Multi-centre Study to assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects with Symptomatic Left Ventricular Systolic Dysfunction and Anemia. 2010 - Ongoing.

Principal Investigator: A Multi-centre, Randomised, Double Blind, Placebo-controlled Study to Evaluate Cardiovascular Outcomes following Treatment with Algoliptin in addition to Standard of Care in Subjects with Type 2 Diabetes and Acute Coronary Syndrome. 2010 – Ongoing.

Principal Investigator: A Multinational Observational Study assessing Insulin Use: Understanding the Challenges associated with Progression of Therapy - The Mosaic Type 2 Diabetes Study. 2011 - Ongoing.

Principal Investigator: A 16 Week, Randomised, Placebo-controlled Study to Evaluate the Efficacy and Safety of Extended Release Niacin/Laropiprant in South and Southeast Asians not on Lipid Modulating Agent, with Decreased High Density Lipo-Protein Cholesterol and Low Density Lipo-Protein Cholesterol at or Below NCEP ATP III Goal. 2011 – Ongoing.

Principal Investigator: A Multi-centre, Prospective, Randomised, Double-Blind, Placebo-controlled, Parallel-Group Study to Evaluate the Effect of AMR101 on Cardiovascular Health and Mortality in Hypertriglyceridemic Patients with Cardiovascular Disease or at High Risk for Cardiovascular Disease: REDUCE-IT. 2011 - Ongoing.

Principal Investigator: A Phase 2, Randomised, Double-Blinded, Placebo-controlled, Dose-Ranging, Parallel Group Study to evaluate Safety and Efficacy of PF-04937319 and Sitagliptin on Glycemic Control in Adult Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin. 2011 - Ongoing.

[-]

Publications

Presentation

Oral Potassium in the Control of Mild Hypertension. Paper Presented at the Update in Cardiology II. Mumbai. 1985.

Presentation

Clinical, Biochemical, Radiological and Pulmonary Function Correlation of 675 Workers Exposed to the Effluents in a Chemical Industry. Paper Presented at the International Conference in Occupational Medicine. Manila. Dec 1985.

[+]

Presentation

Fixed Dose Perindopril in Moderate to Severe Hypertension. 14th World Congress of Heart Disease. Toronto, Canada. 2008.

Presentation

Vitamin D – A Metabolic Modulator. Paper Presented as the Keynote Address at the Annual Convention of the Indian Medical Association (IMA). Dec 2011.

Article

Goldenhar's Syndrome – Craniofacial Dysplasia. Neurology India. Jun 1982.

Article

Cerebrospinal Fluid Haemodynamics. Published in the MD Newsletter of KEM Hospital.

Article

Dygaid - Clinical Experience in 50 Patients. The Bombay Hospital Journal. Vol.35 No. 3. 1995.

Article

Gatifloxacin in Community Acquired Pneumonia – Study presented at the inaugural launch of the new drug. Bombay Hospital Journal. Oct 2001.

Article

The Efficacy of Chirally Pure Amlodipine in Reducing Hypertension and Decreasing Peripheral Edema in Clinical Practice involving 20 Patients. GP Guidelines Newsletter. Pune 2002-2003.

Article

Efficacy of S-Amlodipine in Normotensive Angina Patients. Journal of Indian Medical Association (JIMA). Apr 2007.

Article

A Double Blind Study to Determine the Clinical Efficacy of Chirally Pure Pantoprazole in Comparison with Racemic Pantoprazole. Indian Journal of Gastroenterology. 2007.

Article

Diabetic Control Made Easy. The Week. May 2007.

Article

Malaria. Bombay Indian Medical Association (BIMA). Jul 2008.

Article

Cholesterol and Triglycerides. Indian Menopause Society (IMS) Mirror. Jul 2008.

Article

Textbook Chapter: HDL Increasing Strategies. Association of Physicians of India (API) Textbook of Medicine - Update 2008.

Article

Textbook Chapter: Blood Pressure Control in Diabetic Patients. Association of Physicians of India (API) Textbook of Medicine - Update 2009.

Article

Management of Hypertension with the Fixed Combination of Perindopril and Amlodipine in Daily Clinical Practice. American Journal of Cardiovascular Drugs. 2009.

Article

Effects of a Polypill (Polycap) on Risk Factors in Middle-Aged Individuals without Cardiovascular Disease (TIPS): A Phase II, Double-Blind, Randomised Trial. Lancet-on-Line. Mar 2009 DOI:10.1016/S01406736(09) 0611-5).

Article

Book Chapter: Treatment of Dyslipidemia. API Textbook of Medicine. 2009-2010.

Article

Left Pulmonary Artery Hypoplasia Presenting with Unilateral Hyperluscent Lung. Sunavala AJ, Thacker HP, Khanna JN. Mar 2011.

Article

Efficacy and Safety of Lixivaptan for the Treatment of Euvolemic Hyponatremia in the Outpatient Setting: Results of the HARMONY Study. Abraham W, Decaux G, Josiassen R, Yagil Y, Kopyt N, Thacker H, Manelli M, Bichet DG, Orlandi C. Accepted for Publication in Kidney International. 2011.

Article

Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure. New England Journal Medicine 2013; 368:1210-1219; March 28, 2013.

Article

Superoxide Dismutase – Evidence Based Perspectives to Target the Redox Dysregulation: Update 2013 – Journal of the Association of Physicians of India. Feb 2014.

Article

Status of Vitamin D Deficiency of Patients admitted in Tertiary Care Hospital. Journal of the Association of Physicians of India. 2014.

[-]

Training

Registrar and Tutor in Internal Medicine. KEM Hospital. 1981-1983.

Professor and Diplomate of National Board (DNB) Teacher in Internal Medicine at Jaslok Hospital. 2001 onwards.

[+]

Ask Me(Ask a specific question regarding your health issues, which may be answered by Dr. Hemant P Thacker.)

I agree to be contacted on the mobile number and/or email id provided by me in Ask Me section.

Gallery

Appointment Information

Bhatia Hospital

G-1 Department, Tardeo Road, Tardeo, Mumbai - 400007, Maharashtra

Mon

11:00AM to 01:30PM

By Appointment

Tue

11:00AM to 01:30PM

By Appointment

Wed

11:00AM to 01:30PM

By Appointment

Thu

11:00AM to 01:30PM

By Appointment

Fri

11:00AM to 01:30PM

By Appointment

Sat

12:00PM to 03:00PM

By Appointment

Sun

[+]

[-]

Breach Candy Hospital

60-A, Bhulabhai Desai Road, Breach Candy, Mumbai - 400026, Maharashtra

Mon

Tue

Wed

Thu

09:00AM to 10:30AM

By Appointment

Fri

Sat

Sun

[+]

[-]

Dr. Thacker's Clinic

Sukh Sagar, 4th Floor, NS Patkar Marg, Mumbai - 400007, Maharashtra

Mon

03:00PM to 07:30PM

By Appointment

Tue

03:00PM to 07:30PM

By Appointment

Wed

03:00PM to 07:30PM

By Appointment

Thu

03:00PM to 07:30PM

By Appointment

Fri

03:00PM to 07:30PM

By Appointment

Sat

Sun

[+]

[-]

Jaslok Hospital

15, Dr. Deshmukh Marg, Pedder Road,, Mumbai - 400026, Maharashtra

[+]

[-]

Sir H. N. Reliance Foundation Hospital

Raja Rammohan Roy Rd, Prarthana Samaj, Khetwadi, Girgaon,, Mumbai - 400004, Maharashtra

[+]

[-]

Testimonials

Fellowships

Accreditation

Recognition

Research

Publications

Training

Ask Me(Ask a specific question regarding your health issues, which may be answered by Dr. Hemant P Thacker.)

PERSONAL INFORMATION:

NON-PERSONAL INFORMATION:

Testimonials

Fellowships

Accreditation

Ailments

Recognition

Research

Publications

Training

Ask Me(Ask a specific question regarding your health issues, which may be answered by Dr. Hemant P Thacker.)